These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 30799533)
1. [Current status and challenges of clinical trial on adenocarcinoma of esophagogastric junction]. Zhou Y Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):112-118. PubMed ID: 30799533 [TBL] [Abstract][Full Text] [Related]
2. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction]. Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538 [TBL] [Abstract][Full Text] [Related]
3. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery]. Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study. Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614 [TBL] [Abstract][Full Text] [Related]
5. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors. Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995 [TBL] [Abstract][Full Text] [Related]
6. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: a retrospective study of 136 cases. Duan X; Shang X; Tang P; Jiang H; Yu Z ANZ J Surg; 2018 Apr; 88(4):E264-E267. PubMed ID: 28503799 [TBL] [Abstract][Full Text] [Related]
7. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. Lee IS; Ahn JY; Yook JH; Kim BS World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248 [TBL] [Abstract][Full Text] [Related]
9. [Surgical strategy for adenocarcinoma of esophagogastric junction]. Lu Y; Zhang K; Chen L Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532 [TBL] [Abstract][Full Text] [Related]
10. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option. Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865 [TBL] [Abstract][Full Text] [Related]
11. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study. Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860 [TBL] [Abstract][Full Text] [Related]
12. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction. Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013 [TBL] [Abstract][Full Text] [Related]
13. Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination. Tang A; Sohal D; McNamara M; Murthy SC; Raja S Surg Oncol Clin N Am; 2020 Oct; 29(4):647-653. PubMed ID: 32883464 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction]. Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217 [No Abstract] [Full Text] [Related]
15. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry. Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366 [TBL] [Abstract][Full Text] [Related]
17. Siewert III adenocarcinoma: treatment update. Di Leo A; Zanoni A Updates Surg; 2017 Sep; 69(3):319-325. PubMed ID: 28303519 [TBL] [Abstract][Full Text] [Related]
18. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China. Cao H; Ooi M; Yu Z; Wang Q; Li Z; Lu Q; Wu Y J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176 [TBL] [Abstract][Full Text] [Related]
19. Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction. Hosoda K; Yamashita K; Katada N; Watanabe M Gen Thorac Cardiovasc Surg; 2015 Oct; 63(10):549-56. PubMed ID: 26232357 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery]. Li ZY; Gu YM; Wang WP; Chen LQ Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):109-113. PubMed ID: 35176820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]